Patents - Mobia Medical, Inc.

Mobia Medical Patents

This internet posting serves as notice under 35 U.S.C. §287(a) that the following Mobia Medical, Inc. products may be covered by the following U.S. patents. Each product or brand may also be covered by one or more foreign patents, and additional patent applications may be pending. Products may be sold individually or as part of a system. Certain patents related to methods of using and manufacturing the systems and devices that are part of the product or brand are also listed.

Vivistim®

  • For purposes of clarity, the Vivistim® brand includes, but is not limited to, the Vivistim® Paired VNS™ System and Vivistim Therapy™.
  • This includes neurostimulation systems and devices and related components used for the treatment of stroke survivors.
Patents
  • US8700145
  • US9089707
  • US9333355
  • US9474904
  • US9504831
  • US9522272
  • US9522273
  • US9522274
  • US9533152
  • US11116933
  • US11167130
  • US11638824
  • US12151104
  • DE112009001024.5
  • DE2766089
  • DE3593856
  • FR2766089
  • FR3593856
  • FR4032583
  • GB2766089
  • GB3593856
  • GB4032583
  • AU2009267051

Serenity®

  • This brand includes neurostimulation systems and devices and related components used for the treatment of tinnitus.
Patents
  • US8489185
  • US8666501
  • US8934967
  • US9204998
  • US9265660
  • US9265661
  • US9265662
  • US9265663
  • US9272145
  • US9339654
  • US9345886
  • US9522085
  • US11167130
  • US11471330
  • US12042356
  • DE112009001024.5
  • DE62012075497
  • FR2776121
  • GB2776121

Model 1001 lead

  • This is an implantable vagus nerve lead used as a component of the Vivistim® Paired VNS System, but can also be used as a lead in any neurostimulation therapy.
Patent
  • US11167130

Neurostimulation systems and devices and methods for the treatment of post traumatic stress disorder, obsessive disorders, phobias, and addiction.

  • Neurostimulation systems and devices and methods for the treatment of post traumatic stress disorder, obsessive disorders, phobias, and addiction.
Patents
  • US9089703
  • US10213577
  • US11167130
  • US11554243
  • US12064563

Neurostimulation systems and devices used to combine neural stimulation with therapy or a training.

  • Neurostimulation systems and devices used to combine neural stimulation with therapy or a training to treat a condition.
Patents
  • US8489185
  • US8666501
  • US8700145
  • US8934967
  • US9089703
  • US9089707
  • US9204998
  • US9265660
  • US9265661
  • US9265662
  • US9265663
  • US9272145
  • US9333355
  • US9339654
  • US9345886
  • US9474904
  • US9504831
  • US9522085
  • US9522272
  • US9522273
  • US9522274
  • US9533152
  • US10213577
  • US11116933
  • US11167130
  • US11471330
  • US11554243
  • US11638824
  • DE112009001024.5
  • DE2766089
  • DE3593856
  • DE62012075497
  • GB2766089
  • GB3593856
  • GB4032583
  • FR2766089
  • FR2776121
  • FR4032583
  • FR3593856
  • AU2009267051

Neurostimulation systems and devices used to treat motor deficits or improve motor function.

  • Neurostimulation systems and devices used to combine neural stimulation with movement, therapy or training to treat motor deficits or improve motor function.
Patents
  • US8700145
  • US9089707
  • US9333355
  • US9474904
  • US9504831
  • US9522272
  • US9522273
  • US9522274
  • US9533152
  • US11116933
  • US11167130
  • US11638824
  • DE112009001024.5
  • DE2766089
  • DE3593856
  • FR2766089
  • FR3593856
  • FR4032583
  • GB2766089
  • GB3593856
  • GB4032583
  • AU2009267051

26-0015-0009 Rev. 0